loader2
NRI

Feb 17, 2025


Category

Equity

AUM (Cr.)

301.61

Exit Load (%)

1.00

Min Inv Lumpsum

500

Expense Ratio

2.36

Sharpe Ratio

0.00

Beta Ratio

0.00

Fund Manager

Nimesh Chandan

Inception Date

Dec 27, 2024

Risk Level

Very High

Investment Objective

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.

Invest Now

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Bajaj Finserv Healthcare Fund - Regular (G) -7.49 0 0 0 0 -10.68
Benchmark - S&P BSE Healthcare TRI -1.88 10.85 37 11.94 22.91 0
Category Average - BEST EQUITY PERFORMERS -6.33 -10.28 5.01 15.26 18.47 9.45
Category Rank 6/10 4/10 6/10 7/10 7/10 10/10
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Nippon India Taiwan Equity Fund (IDCW) 11.8515 1.47 6.91 8.30 0.00 358.16 2.44 500.00 invest
Nippon India Taiwan Equity Fund (G) 11.8515 1.47 6.91 8.30 0.00 358.16 2.44 500.00 invest
Nippon India Pharma Fund (IDCW) 119.7788 1.26 8.44 18.38 23.64 8,160.74 1.82 5,000.00 invest
Nippon India Pharma Fund (G) 470.4532 1.26 8.44 18.38 23.88 8,160.74 1.82 5,000.00 invest
DSP Healthcare Fund (G) 37.3700 -2.41 15.73 20.30 24.83 3,197.52 0.00 100.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)
4 Months Trends
Equity-Divi`s Lab. Jan 31, 2025 26.37 8.74 0.00
Equity-Sun Pharma.Inds. Jan 31, 2025 26.10 8.65 0.00
Equity-Dr Reddy`s Labs Jan 31, 2025 25.53 8.46 0.00
Equity-Cipla Jan 31, 2025 21.63 7.17 0.00
Net CA & Others-Net CA & Others Jan 31, 2025 20.80 6.89 0.00
Equity-Apollo Hospitals Jan 31, 2025 15.92 5.28 0.00
Equity-Biocon Jan 31, 2025 12.78 4.24 0.00
Equity-Piramal Pharma Jan 31, 2025 12.01 3.98 0.00
Equity-Neuland Labs. Jan 31, 2025 9.91 3.29 0.00
Equity-Syngene Intl. Jan 31, 2025 9.82 3.25 0.00

latest news

Bajaj MF announces change in Fund Manager of the following schemes

Bajaj Mutual Fund has announced change in Fund Managers of the following sc...

Dec 13, 2024 11:43

Bajaj Finserv Nifty 1D Rate Liquid ETF Announces Extension of NFO period

Bajaj Finserv Mutual Fund has announced that theclosing date of New Fund Of...

May 15, 2024 12:19

Bajaj Finserv MF Announces change in fund managers under its scheme

Bajaj Finserv Mutual Fund has announced change in fund managers under the f...

Mar 30, 2024 11:06

Bajaj Finserv files for multi asset allocation fund: targets long-term growth with diversified investment strategy

Bajaj Finserv has filed for a new open-ended mutual fund scheme � the Bajaj...

Mar 25, 2024 12:57

Bajaj Finserv Mutual Fund Change in Minimum Application Amount

Bajaj Finserv Mutual Fund Announces that the Minimum Application Amount for...

Jan 25, 2024 15:09

Bajaj Finserv Banking and PSU Fund Announces Extension of NFO period

Bajaj Finserv Mutual Fund has announced that the New Fund Offer Period(NFO)...

Oct 23, 2023 09:49

SCHEME DETAILS

AMC Name : Bajaj Finserv Mutual Fund
Fund Name : Bajaj Finserv Healthcare Fund - Regular (G)
Contact Persone : Nimesh Chandan
Registered Address : S. No. 208-1B, Off Pune AhmednagarRoad, Lohagaon, Viman Nagar,Pune 411014
Telephone No : 020-67672500
Fax No. : 020-67672550
Email : service:bajajamc.com
Website : WWW.bajajamc.com